Fredrick D. Cobb Appointed Vice President Of Finance At Advaxis, Inc.

NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Feb. 28, 2006--Advaxis, Inc. (OTCBB: ADXS), a developer of Listeria based cancer vaccines, has added to its management team Fredrick D. Cobb as VP of Finance. Mr. Cobb is an accomplished financial professional with a 30-year record of successfully managing corporate finance, operations, and accounting within the biotechnology and Fortune 100 pharmaceutical sectors. His career includes high management positions with Bristol-Myers Squibb, Emisphere Technologies Inc, and most recently with Metaphore Pharmaceuticals. He possesses both knowledge of and experience working with US GAAP requirements, SEC reporting, and Sarbanes-Oxley Act implementation. He has also liaised with external auditors and prepared initial public offering documentation for companies involved in the development and commercialization of new chemical entities.